Telerehabilitation Market Size, Trends, Share, Growth | Report 2023-2032
The global telerehabilitation market was surpassed at USD 3.56 billion in 2022 and is expected to hit around USD 14.81 billion by 2032, growing at a CAGR of 15.32% from 2023 to 2032.
Key Pointers
| Report Coverage | Details |
| Market Size in 2022 | USD 3.56 billion |
| Revenue Forecast by 2032 | USD 14.81 billion |
| Growth rate from 2023 to 2032 | CAGR of 15.32% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Telerehabilitation, commonly referred to as e-rehabilitation is the provision of rehabilitation services via a telecommunication network and the internet. Medical professionals can remotely communicate with patients using telerehabilitation services and diagnose the patients & administer therapy. Physical therapy, speech-language, occupational therapy, audiology, audiology, and psychology are among the medical specialties that use telerehabilitation. Exercises for the motor system, speech therapy, robotic treatment, virtual reality, goal setting, and group exercise are among the various therapy modalities.
Increased instances of various disorders such as traumatic brain injury, cerebrovascular accidents, and developmental delays in the pediatric population are some of the factors expected to increase the demand for telerehabilitation services globally. These conditions hamper the physical movement of the patient thereby, increasing the demand for these services. Also, telerehabilitation helps to curb healthcare costs considerably as the patient visit to hospitals to meet the physicians for rehabilitation services are reduced which is further anticipated to drive the market growth.
Further, the rising adoption of digital technologies in the healthcare industry, as well as the increasing penetration of the smartphones and internet globally, is expected to drive the telerehabilitation market. In addition, various initiatives are undertaken by both public and private institutions. For instance, the American Telemedicine Association's Telemedicine Special Interest Group Special is a key resource for rehabilitation professionals who want to incorporate information and communication technologies into clinical best practices, advocacy, and the delivery of rehabilitation services. These initiatives are credited with increasing awareness of telerehabilitation services, which is expected to drive market growth.
Telerehabilitation services witnessed a significant boost during the COVID-19 pandemic due to the restrictions that were imposed on the movement of people, cancellation of non-essential procedures, and conversion of wards into COVID wards in order to treat the increasing number of patients. As per a study published by NCBI in 2021, 37% of clinicians administered care via telerehabilitation.
Key Companies & Market Share Insights
High competition in the market due to innovative product offerings by key players and the entry of new players has led to high market growth. For instance, NeoRehab introduced a new eHAB platform in 2020 to meet the demand of patients with chronic pain who reside in remote locations. With the help of this new technology, primary care professionals should be able to deliver telehealth services and improve teleconsultation functionality, dependability, affordability, and patient security. Some of the prominent players in global telerehabilitation market include:
Telerehabilitation Market Segmentations:
| By Component | By Services | By Therapy | By Application |
|
Hardware Software |
Clinical Assessment Clinical Therapy |
Physical Therapy Occupational Therapy Others |
Cardiovascular Orthopedic Neurology Pediatric Others |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Telerehabilitation Market
5.1. COVID-19 Landscape: Telerehabilitation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Telerehabilitation Market, By Component
8.1. Telerehabilitation Market, by Component, 2023-2032
8.1.1. Hardware
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Telerehabilitation Market, By Services
9.1. Telerehabilitation Market, by Services, 2023-2032
9.1.1. Clinical Assessment
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Clinical Therapy
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Telerehabilitation Market, By Therapy
10.1. Telerehabilitation Market, by Therapy, 2023-2032
10.1.1. Physical Therapy
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Occupational Therapy
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Telerehabilitation Market, By Application
11.1. Telerehabilitation Market, by Application, 2023-2032
11.1.1. Cardiovascular
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Orthopedic
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Neurology
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Pediatric
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Telerehabilitation Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Component (2020-2032)
12.1.2. Market Revenue and Forecast, by Services (2020-2032)
12.1.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.1.4. Market Revenue and Forecast, by Application (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Component (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Services (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.1.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Component (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Services (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.1.6.4. Market Revenue and Forecast, by Application (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Component (2020-2032)
12.2.2. Market Revenue and Forecast, by Services (2020-2032)
12.2.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.2.4. Market Revenue and Forecast, by Application (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Component (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Services (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.2.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Component (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Services (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.2.6.4. Market Revenue and Forecast, by Application (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Component (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Services (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.2.7.4. Market Revenue and Forecast, by Application (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Component (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Services (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.2.8.4. Market Revenue and Forecast, by Application (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Component (2020-2032)
12.3.2. Market Revenue and Forecast, by Services (2020-2032)
12.3.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.3.4. Market Revenue and Forecast, by Application (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Component (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Services (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.3.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Component (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Services (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.3.6.4. Market Revenue and Forecast, by Application (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Component (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Services (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.3.7.4. Market Revenue and Forecast, by Application (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Component (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Services (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.3.8.4. Market Revenue and Forecast, by Application (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Component (2020-2032)
12.4.2. Market Revenue and Forecast, by Services (2020-2032)
12.4.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.4.4. Market Revenue and Forecast, by Application (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Component (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Services (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.4.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Component (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Services (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.4.6.4. Market Revenue and Forecast, by Application (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Component (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Services (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.4.7.4. Market Revenue and Forecast, by Application (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Component (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Services (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.4.8.4. Market Revenue and Forecast, by Application (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Component (2020-2032)
12.5.2. Market Revenue and Forecast, by Services (2020-2032)
12.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Component (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Services (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.5.5.4. Market Revenue and Forecast, by Application (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Component (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Services (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Therapy (2020-2032)
12.5.6.4. Market Revenue and Forecast, by Application (2020-2032)
Chapter 13. Company Profiles
13.1. American Well
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Doctor On Demand, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Hinge Health, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. MIRA Rehab Limited
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Koninklijke Philips N.V
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Cisco
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. NeoRehab
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Jintronix
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. C3O telemedicine
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Care Innovation, LLC.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers